We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

DRCR Protocol AC – Aflibercept vs. Bevacizumab with Deferred Aflibercept for Diabetic Macular Edema

Purpose of Study

To find out if starting with Eylea has better results than starting with the less expensive drug, Avastin, and only switching to Eylea if needed in patients who have diabetic macular edema.

  • Study in follow-up phase only; Enrollment Complete

How to Contact Us

Principal Investigator: Shree Kurup, MD
Study Coordinator: Leslie Richards | 216-844-7934